在多抗药性大肠杆菌菌株中产生梅罗胺耐药性的发展,在血液恶性病患者中引起复发性细菌病
María Bonilla-Moreno1, Miriam Torrecillas1, Julia Laporte-Amargos2
1Department of Microbiology, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain.
Antimicrobial agents and chemotherapy
|June 26, 2023
概括
抗多种药物抗性大肠杆菌菌病很少见,特别是在免疫功能低下的患者中. 这一案例突出显示了单一治疗期间的美罗耐药性发展以及通过免疫支持和肠道脱殖的成功治疗.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 坎比洛巴克特细菌病是不常见的,主要影响免疫力低下的人.
- 大肠杆菌菌株表现出越来越多的抗生素耐药性,这给治疗带来了挑战.
- 耐多药性 (MDR) 感染需要新的治疗策略.
研究的目的:
- 报告一种持续的多药耐药性大肠杆菌菌血病病例.
- 描述单独治疗期间美罗胺耐药性的发展.
- 评估联合免疫支持和肠道脱殖的疗效.
主要方法:
- 一个病人的病例报告,患有持续的C.大肠杆菌血症超过3个月.
- 在治疗期间监测抗生素敏感性.
- 干预包括改善免疫状态和肠道脱殖民主义治疗.
主要成果:
- 由于MDR大肠杆菌菌株,该患者患有持续性细菌血症.
- 单独使用美罗的疗法导致了美罗耐药性的出现.
- 结合疗法改善了免疫力,并实现了肠道脱殖,控制了感染.
结论:
- 持续的MDRCampylobacter coli细菌病是一个重大的临床挑战.
- 抗生素单一治疗可以推动大肠杆菌感染中耐药性的发展.
- 综合治疗方法,包括免疫调节和脱殖,对于管理持续性大肠杆菌感染至关重要.
关键词:
坎比洛巴克特大肠杆菌 (Campylobacter coli) 是一个大肠杆菌.血流感染 感染 感染血液感染 血液感染血液病患者的血液病患者.更多的是openemenem.多种药物耐药性多种药物耐药性多重耐药性多重耐药性全基因组测序 (WGS) 是一种全基因组测序.更多相关视频
相关概念视频
Development of Antibiotic Resistance
46
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
46
Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


